A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZD7687 After Administration of Single and Multiple Ascending Doses in Healthy Male Japanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2012
At a glance
- Drugs AZD 7687 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms JSMAD
- 12 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 12 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Nov 2010 Additional location (England) identified as reported by ClinicalTrials.gov.